FDA GOOD REVIEW PRACTICES COMMITTEE WILL BREAK INTO GROUPS
This article was originally published in The Tan Sheet
Executive Summary
FDA GOOD REVIEW PRACTICES COMMITTEE WILL BREAK INTO GROUPS to begin development of an "action plan" at a meeting set for Nov. 21, the agency said. The meeting also will feature discussion of "the results of the initial workshops" and will "solicit input on the project from staff involved in the review of INDs, NDAs, and PLAs," FDA said.
New to Pink Sheet?
Start a free trial today!
Register for our free email digests:
Register for our free email digests: